Engineering of a novel zipFv using leucine zipper motif against rabies virus glycoprotein G with improved protection potency in vivo

Hampson, 2015, Estimating the global burden of endemic canine rabies, PLoS Negl. Trop. Dis., 9, e0003709, 10.1371/journal.pntd.0003709 Shantavasinkul, 2011, Postexposure prophylaxis for rabies in resource-limited/poor countries, Adv. Virus Res., 79, 291, 10.1016/B978-0-12-387040-7.00013-5 Both, 2012, Passive immunity in the prevention of rabies, Lancet Infect. Dis., 12, 397, 10.1016/S1473-3099(11)70340-1 Nagarajan, 2014, Monoclonal antibodies for the prevention of rabies: theory and clinical practice, Antib. Technol. J., 4, 1, 10.2147/ANTI.S33533 Bird, 1988, Single-chain antigen-binding proteins, Science, 242, 423, 10.1126/science.3140379 Weisser, 2009, Applications of single-chain variable fragment antibodies in therapeutics and diagnostics, Biotechnol. Adv., 27, 502, 10.1016/j.biotechadv.2009.04.004 Wörn, 2001, Stability engineering of antibody single-chain Fv fragments 1, J. Mol. Biol., 305, 989, 10.1006/jmbi.2000.4265 Landschulz, 1988, The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins, Science, 240, 1759, 10.1126/science.3289117 Kouzarides, 1988, The role of the leucine zipper in the fos-jun interaction, Nature, 336, 646, 10.1038/336646a0 Kostelny, 1992, Formation of a bispecific antibody by the use of leucine zippers, J. Immunol., 148, 1547, 10.4049/jimmunol.148.5.1547 O'Shea, 1989, Preferential heterodimer formation by isolated leucine zippers from fos and jun, Science, 245, 646, 10.1126/science.2503872 De, 1996, Leucine zipper dimerized bivalent and bispecific scFv antibodies from a semi-synthetic antibody phage display library, J. Biol. Chem., 271, 7630, 10.1074/jbc.271.13.7630 Yuan, 2014, Preparation and diagnostic use of a novel recombinant single-chain antibody against rabies virus glycoprotein, Appl. Microbiol. Biotechnol., 98, 1547, 10.1007/s00253-013-5351-6 Li, 2015, A novel variable antibody fragment dimerized by leucine zippers with enhanced neutralizing potency against rabies virus G protein compared to its corresponding single-chain variable antibody fragment, Mol. Immunol., 68, 168, 10.1016/j.molimm.2015.06.027 Beatty, 1987, Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay, J. Immunol. Methods, 100, 173, 10.1016/0022-1759(87)90187-6 Reed, 1937, A simple method of estimating fifty per cent endpoints, Am. J. Trop. Med. Hyg., 27 Duan, 2014, Negative effects of a disulfide bond mismatch in anti-rabies G protein single-chain antibody variable fragment FV57, Mol. Immunol., 59, 136, 10.1016/j.molimm.2014.01.006 Duan, 2012, A novel disulfide-stabilized single-chain variable antibody fragment against rabies virus G protein with enhanced in vivo neutralizing potency, Mol. Immunol., 51, 188, 10.1016/j.molimm.2012.03.015 Goudsmit, 2006, Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin, J. Infect. Dis., 193, 796, 10.1086/500470 Bakker, 2005, Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants, J. Virol., 79, 9062, 10.1128/JVI.79.14.9062-9068.2005 Frenzel, 2013, Expression of recombinant antibodies, Front. Immunol., 4, 1, 10.3389/fimmu.2013.00217 Lee, 2013, Intracellular reprogramming of expression, glycosylation, and function of a plant-derived antiviral therapeutic monoclonal antibody, PLoS One, 8, 1 Marissen, 2005, Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis, J. Virol., 79, 4672, 10.1128/JVI.79.8.4672-4678.2005 Terryn, 2014, Protective effect of different anti-rabies virus VHH constructs against rabies disease in mice, PLoS One, 9, 1, 10.1371/journal.pone.0109367 Dietzschold, 1992, Delineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system, Proc. Natl. Acad. Sci. U. S. A., 89, 7252, 10.1073/pnas.89.15.7252 Tuffereau, 2007, The rabies virus glycoprotein receptor p75NTR is not essential for rabies virus infection, J. Virol., 81, 13622, 10.1128/JVI.02368-06